Women's health is a science aimed at maintaining and promoting women's health. It takes groups as its service and research objects, focuses on prevention, and closely integrates with clinical practice. The level of women’s health care in a country is closely linked to the political, economic and social status of women in that country. Over the past 50 years, my country’s women’s health undertakings have made great progress, but there are still many problems with the improvement of women’s health and women’s physical and mental health across the country, and further efforts are needed.、

The global Women’s Health Drugs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Women’s Health Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Women’s Health Drugs.

Report Scope

The Women’s Health Drugs market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Women’s Health Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Women’s Health Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Women’s Health Drugs Market Report

Report Metric	Details
Report Name	Women’s Health Drugs Market
CAGR	5%
Segment by Type	EVISTA XGEVA Prolia Mirena Zometa Reclast/Aclasta Minastrin 24 Fe Others (Premarin, ACTONEL, ORTHO TRI-CY LO)
Segment by Application	Hormonal Infertility Postmenopausal Osteoporosis Endometriosis Contraceptives Menopause Polycystic Ovary Syndrome Other Applications
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Bayer AG, Allergan, Merck & Co, Pfizer Inc, Amgen, Agile Therapeutics Inc, Ferring Pharmaceuticals, Mylan N.V., Lupin (India), Eli Lilly And Company, Novartis AG, Johnson & Johnson
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Women’s Health Drugs companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Women’s Health Drugs Market report?

Ans: The main players in the Women’s Health Drugs Market are Bayer AG, Allergan, Merck & Co, Pfizer Inc, Amgen, Agile Therapeutics Inc, Ferring Pharmaceuticals, Mylan N.V., Lupin (India), Eli Lilly And Company, Novartis AG, Johnson & Johnson

What are the Application segmentation covered in the Women’s Health Drugs Market report?

Ans: The Applications covered in the Women’s Health Drugs Market report are Hormonal Infertility, Postmenopausal Osteoporosis, Endometriosis, Contraceptives, Menopause, Polycystic Ovary Syndrome, Other Applications

What are the Type segmentation covered in the Women’s Health Drugs Market report?

Ans: The Types covered in the Women’s Health Drugs Market report are EVISTA, XGEVA, Prolia, Mirena, Zometa, Reclast/Aclasta, Minastrin 24 Fe, Others (Premarin, ACTONEL, ORTHO TRI-CY LO)

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Women’s Health Drugs Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 EVISTA

1.2.3 XGEVA

1.2.4 Prolia

1.2.5 Mirena

1.2.6 Zometa

1.2.7 Reclast/Aclasta

1.2.8 Minastrin 24 Fe

1.2.9 Others (Premarin, ACTONEL, ORTHO TRI-CY LO)

1.3 Market by Application

1.3.1 Global Women’s Health Drugs Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Hormonal Infertility

1.3.3 Postmenopausal Osteoporosis

1.3.4 Endometriosis

1.3.5 Contraceptives

1.3.6 Menopause

1.3.7 Polycystic Ovary Syndrome

1.3.8 Other Applications

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global Women’s Health Drugs Market Perspective (2019-2030)

2.2 Women’s Health Drugs Growth Trends by Region

2.2.1 Global Women’s Health Drugs Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Women’s Health Drugs Historic Market Size by Region (2019-2024)

2.2.3 Women’s Health Drugs Forecasted Market Size by Region (2025-2030)

2.3 Women’s Health Drugs Market Dynamics

2.3.1 Women’s Health Drugs Industry Trends

2.3.2 Women’s Health Drugs Market Drivers

2.3.3 Women’s Health Drugs Market Challenges

2.3.4 Women’s Health Drugs Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Women’s Health Drugs Players by Revenue

3.1.1 Global Top Women’s Health Drugs Players by Revenue (2019-2024)

3.1.2 Global Women’s Health Drugs Revenue Market Share by Players (2019-2024)

3.2 Global Women’s Health Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Women’s Health Drugs Revenue

3.4 Global Women’s Health Drugs Market Concentration Ratio

3.4.1 Global Women’s Health Drugs Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Women’s Health Drugs Revenue in 2023

3.5 Women’s Health Drugs Key Players Head office and Area Served

3.6 Key Players Women’s Health Drugs Product Solution and Service

3.7 Date of Enter into Women’s Health Drugs Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Women’s Health Drugs Breakdown Data by Type

4.1 Global Women’s Health Drugs Historic Market Size by Type (2019-2024)

4.2 Global Women’s Health Drugs Forecasted Market Size by Type (2025-2030)

5 Women’s Health Drugs Breakdown Data by Application

5.1 Global Women’s Health Drugs Historic Market Size by Application (2019-2024)

5.2 Global Women’s Health Drugs Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Women’s Health Drugs Market Size (2019-2030)

6.2 North America Women’s Health Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Women’s Health Drugs Market Size by Country (2019-2024)

6.4 North America Women’s Health Drugs Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Women’s Health Drugs Market Size (2019-2030)

7.2 Europe Women’s Health Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Women’s Health Drugs Market Size by Country (2019-2024)

7.4 Europe Women’s Health Drugs Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Women’s Health Drugs Market Size (2019-2030)

8.2 Asia-Pacific Women’s Health Drugs Market Growth Rate by Region: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Women’s Health Drugs Market Size by Region (2019-2024)

8.4 Asia-Pacific Women’s Health Drugs Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Women’s Health Drugs Market Size (2019-2030)

9.2 Latin America Women’s Health Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Women’s Health Drugs Market Size by Country (2019-2024)

9.4 Latin America Women’s Health Drugs Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Women’s Health Drugs Market Size (2019-2030)

10.2 Middle East & Africa Women’s Health Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Women’s Health Drugs Market Size by Country (2019-2024)

10.4 Middle East & Africa Women’s Health Drugs Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Bayer AG

11.1.1 Bayer AG Company Detail

11.1.2 Bayer AG Business Overview

11.1.3 Bayer AG Women’s Health Drugs Introduction

11.1.4 Bayer AG Revenue in Women’s Health Drugs Business (2019-2024)

11.1.5 Bayer AG Recent Development

11.2 Allergan

11.2.1 Allergan Company Detail

11.2.2 Allergan Business Overview

11.2.3 Allergan Women’s Health Drugs Introduction

11.2.4 Allergan Revenue in Women’s Health Drugs Business (2019-2024)

11.2.5 Allergan Recent Development

11.3 Merck & Co

11.3.1 Merck & Co Company Detail

11.3.2 Merck & Co Business Overview

11.3.3 Merck & Co Women’s Health Drugs Introduction

11.3.4 Merck & Co Revenue in Women’s Health Drugs Business (2019-2024)

11.3.5 Merck & Co Recent Development

11.4 Pfizer Inc

11.4.1 Pfizer Inc Company Detail

11.4.2 Pfizer Inc Business Overview

11.4.3 Pfizer Inc Women’s Health Drugs Introduction

11.4.4 Pfizer Inc Revenue in Women’s Health Drugs Business (2019-2024)

11.4.5 Pfizer Inc Recent Development

11.5 Amgen

11.5.1 Amgen Company Detail

11.5.2 Amgen Business Overview

11.5.3 Amgen Women’s Health Drugs Introduction

11.5.4 Amgen Revenue in Women’s Health Drugs Business (2019-2024)

11.5.5 Amgen Recent Development

11.6 Agile Therapeutics Inc

11.6.1 Agile Therapeutics Inc Company Detail

11.6.2 Agile Therapeutics Inc Business Overview

11.6.3 Agile Therapeutics Inc Women’s Health Drugs Introduction

11.6.4 Agile Therapeutics Inc Revenue in Women’s Health Drugs Business (2019-2024)

11.6.5 Agile Therapeutics Inc Recent Development

11.7 Ferring Pharmaceuticals

11.7.1 Ferring Pharmaceuticals Company Detail

11.7.2 Ferring Pharmaceuticals Business Overview

11.7.3 Ferring Pharmaceuticals Women’s Health Drugs Introduction

11.7.4 Ferring Pharmaceuticals Revenue in Women’s Health Drugs Business (2019-2024)

11.7.5 Ferring Pharmaceuticals Recent Development

11.8 Mylan N.V.

11.8.1 Mylan N.V. Company Detail

11.8.2 Mylan N.V. Business Overview

11.8.3 Mylan N.V. Women’s Health Drugs Introduction

11.8.4 Mylan N.V. Revenue in Women’s Health Drugs Business (2019-2024)

11.8.5 Mylan N.V. Recent Development

11.9 Lupin (India)

11.9.1 Lupin (India) Company Detail

11.9.2 Lupin (India) Business Overview

11.9.3 Lupin (India) Women’s Health Drugs Introduction

11.9.4 Lupin (India) Revenue in Women’s Health Drugs Business (2019-2024)

11.9.5 Lupin (India) Recent Development

11.10 Eli Lilly And Company

11.10.1 Eli Lilly And Company Company Detail

11.10.2 Eli Lilly And Company Business Overview

11.10.3 Eli Lilly And Company Women’s Health Drugs Introduction

11.10.4 Eli Lilly And Company Revenue in Women’s Health Drugs Business (2019-2024)

11.10.5 Eli Lilly And Company Recent Development

11.11 Novartis AG

11.11.1 Novartis AG Company Detail

11.11.2 Novartis AG Business Overview

11.11.3 Novartis AG Women’s Health Drugs Introduction

11.11.4 Novartis AG Revenue in Women’s Health Drugs Business (2019-2024)

11.11.5 Novartis AG Recent Development

11.12 Johnson & Johnson

11.12.1 Johnson & Johnson Company Detail

11.12.2 Johnson & Johnson Business Overview

11.12.3 Johnson & Johnson Women’s Health Drugs Introduction

11.12.4 Johnson & Johnson Revenue in Women’s Health Drugs Business (2019-2024)

11.12.5 Johnson & Johnson Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Agile Therapeutics Inc

Ferring Pharmaceuticals

Mylan N.V.

Lupin (India)

Eli Lilly and Company

Novartis

Johnson & Johnson

List of Tables

Table 1. Global Women’s Health Drugs Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of EVISTA

Table 3. Key Players of XGEVA

Table 4. Key Players of Prolia

Table 5. Key Players of Mirena

Table 6. Key Players of Zometa

Table 7. Key Players of Reclast/Aclasta

Table 8. Key Players of Minastrin 24 Fe

Table 9. Key Players of Others (Premarin, ACTONEL, ORTHO TRI-CY LO)

Table 10. Global Women’s Health Drugs Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 11. Global Women’s Health Drugs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 12. Global Women’s Health Drugs Market Size by Region (2019-2024) & (US$ Million)

Table 13. Global Women’s Health Drugs Market Share by Region (2019-2024)

Table 14. Global Women’s Health Drugs Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 15. Global Women’s Health Drugs Market Share by Region (2025-2030)

Table 16. Women’s Health Drugs Market Trends

Table 17. Women’s Health Drugs Market Drivers

Table 18. Women’s Health Drugs Market Challenges

Table 19. Women’s Health Drugs Market Restraints

Table 20. Global Women’s Health Drugs Revenue by Players (2019-2024) & (US$ Million)

Table 21. Global Women’s Health Drugs Market Share by Players (2019-2024)

Table 22. Global Top Women’s Health Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Women’s Health Drugs as of 2023)

Table 23. Ranking of Global Top Women’s Health Drugs Companies by Revenue (US$ Million) in 2023

Table 24. Global 5 Largest Players Market Share by Women’s Health Drugs Revenue (CR5 and HHI) & (2019-2024)

Table 25. Key Players Headquarters and Area Served

Table 26. Key Players Women’s Health Drugs Product Solution and Service

Table 27. Date of Enter into Women’s Health Drugs Market

Table 28. Mergers & Acquisitions, Expansion Plans

Table 29. Global Women’s Health Drugs Market Size by Type (2019-2024) & (US$ Million)

Table 30. Global Women’s Health Drugs Revenue Market Share by Type (2019-2024)

Table 31. Global Women’s Health Drugs Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 32. Global Women’s Health Drugs Revenue Market Share by Type (2025-2030)

Table 33. Global Women’s Health Drugs Market Size by Application (2019-2024) & (US$ Million)

Table 34. Global Women’s Health Drugs Revenue Market Share by Application (2019-2024)

Table 35. Global Women’s Health Drugs Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 36. Global Women’s Health Drugs Revenue Market Share by Application (2025-2030)

Table 37. North America Women’s Health Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 38. North America Women’s Health Drugs Market Size by Country (2019-2024) & (US$ Million)

Table 39. North America Women’s Health Drugs Market Size by Country (2025-2030) & (US$ Million)

Table 40. Europe Women’s Health Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 41. Europe Women’s Health Drugs Market Size by Country (2019-2024) & (US$ Million)

Table 42. Europe Women’s Health Drugs Market Size by Country (2025-2030) & (US$ Million)

Table 43. Asia-Pacific Women’s Health Drugs Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030

Table 44. Asia-Pacific Women’s Health Drugs Market Size by Region (2019-2024) & (US$ Million)

Table 45. Asia-Pacific Women’s Health Drugs Market Size by Region (2025-2030) & (US$ Million)

Table 46. Latin America Women’s Health Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 47. Latin America Women’s Health Drugs Market Size by Country (2019-2024) & (US$ Million)

Table 48. Latin America Women’s Health Drugs Market Size by Country (2025-2030) & (US$ Million)

Table 49. Middle East & Africa Women’s Health Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 50. Middle East & Africa Women’s Health Drugs Market Size by Country (2019-2024) & (US$ Million)

Table 51. Middle East & Africa Women’s Health Drugs Market Size by Country (2025-2030) & (US$ Million)

Table 52. Bayer AG Company Detail

Table 53. Bayer AG Business Overview

Table 54. Bayer AG Women’s Health Drugs Product

Table 55. Bayer AG Revenue in Women’s Health Drugs Business (2019-2024) & (US$ Million)

Table 56. Bayer AG Recent Development

Table 57. Allergan Company Detail

Table 58. Allergan Business Overview

Table 59. Allergan Women’s Health Drugs Product

Table 60. Allergan Revenue in Women’s Health Drugs Business (2019-2024) & (US$ Million)

Table 61. Allergan Recent Development

Table 62. Merck & Co Company Detail

Table 63. Merck & Co Business Overview

Table 64. Merck & Co Women’s Health Drugs Product

Table 65. Merck & Co Revenue in Women’s Health Drugs Business (2019-2024) & (US$ Million)

Table 66. Merck & Co Recent Development

Table 67. Pfizer Inc Company Detail

Table 68. Pfizer Inc Business Overview

Table 69. Pfizer Inc Women’s Health Drugs Product

Table 70. Pfizer Inc Revenue in Women’s Health Drugs Business (2019-2024) & (US$ Million)

Table 71. Pfizer Inc Recent Development

Table 72. Amgen Company Detail

Table 73. Amgen Business Overview

Table 74. Amgen Women’s Health Drugs Product

Table 75. Amgen Revenue in Women’s Health Drugs Business (2019-2024) & (US$ Million)

Table 76. Amgen Recent Development

Table 77. Agile Therapeutics Inc Company Detail

Table 78. Agile Therapeutics Inc Business Overview

Table 79. Agile Therapeutics Inc Women’s Health Drugs Product

Table 80. Agile Therapeutics Inc Revenue in Women’s Health Drugs Business (2019-2024) & (US$ Million)

Table 81. Agile Therapeutics Inc Recent Development

Table 82. Ferring Pharmaceuticals Company Detail

Table 83. Ferring Pharmaceuticals Business Overview

Table 84. Ferring Pharmaceuticals Women’s Health Drugs Product

Table 85. Ferring Pharmaceuticals Revenue in Women’s Health Drugs Business (2019-2024) & (US$ Million)

Table 86. Ferring Pharmaceuticals Recent Development

Table 87. Mylan N.V. Company Detail

Table 88. Mylan N.V. Business Overview

Table 89. Mylan N.V. Women’s Health Drugs Product

Table 90. Mylan N.V. Revenue in Women’s Health Drugs Business (2019-2024) & (US$ Million)

Table 91. Mylan N.V. Recent Development

Table 92. Lupin (India) Company Detail

Table 93. Lupin (India) Business Overview

Table 94. Lupin (India) Women’s Health Drugs Product

Table 95. Lupin (India) Revenue in Women’s Health Drugs Business (2019-2024) & (US$ Million)

Table 96. Lupin (India) Recent Development

Table 97. Eli Lilly And Company Company Detail

Table 98. Eli Lilly And Company Business Overview

Table 99. Eli Lilly And Company Women’s Health Drugs Product

Table 100. Eli Lilly And Company Revenue in Women’s Health Drugs Business (2019-2024) & (US$ Million)

Table 101. Eli Lilly And Company Recent Development

Table 102. Novartis AG Company Detail

Table 103. Novartis AG Business Overview

Table 104. Novartis AG Women’s Health Drugs Product

Table 105. Novartis AG Revenue in Women’s Health Drugs Business (2019-2024) & (US$ Million)

Table 106. Novartis AG Recent Development

Table 107. Johnson & Johnson Company Detail

Table 108. Johnson & Johnson Business Overview

Table 109. Johnson & Johnson Women’s Health Drugs Product

Table 110. Johnson & Johnson Revenue in Women’s Health Drugs Business (2019-2024) & (US$ Million)

Table 111. Johnson & Johnson Recent Development

Table 112. Research Programs/Design for This Report

Table 113. Key Data Information from Secondary Sources

Table 114. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Women’s Health Drugs Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 2. Global Women’s Health Drugs Market Share by Type: 2023 VS 2030

Figure 3. EVISTA Features

Figure 4. XGEVA Features

Figure 5. Prolia Features

Figure 6. Mirena Features

Figure 7. Zometa Features

Figure 8. Reclast/Aclasta Features

Figure 9. Minastrin 24 Fe Features

Figure 10. Others (Premarin, ACTONEL, ORTHO TRI-CY LO) Features

Figure 11. Global Women’s Health Drugs Market Size Comparison by Application (2024-2030) & (US$ Million)

Figure 12. Global Women’s Health Drugs Market Share by Application: 2023 VS 2030

Figure 13. Hormonal Infertility Case Studies

Figure 14. Postmenopausal Osteoporosis Case Studies

Figure 15. Endometriosis Case Studies

Figure 16. Contraceptives Case Studies

Figure 17. Menopause Case Studies

Figure 18. Polycystic Ovary Syndrome Case Studies

Figure 19. Other Applications Case Studies

Figure 20. Women’s Health Drugs Report Years Considered

Figure 21. Global Women’s Health Drugs Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 22. Global Women’s Health Drugs Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 23. Global Women’s Health Drugs Market Share by Region: 2023 VS 2030

Figure 24. Global Women’s Health Drugs Market Share by Players in 2023

Figure 25. Global Top Women’s Health Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Women’s Health Drugs as of 2023)

Figure 26. The Top 10 and 5 Players Market Share by Women’s Health Drugs Revenue in 2023

Figure 27. North America Women’s Health Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. North America Women’s Health Drugs Market Share by Country (2019-2030)

Figure 29. United States Women’s Health Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Canada Women’s Health Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Europe Women’s Health Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Europe Women’s Health Drugs Market Share by Country (2019-2030)

Figure 33. Germany Women’s Health Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. France Women’s Health Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. U.K. Women’s Health Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. Italy Women’s Health Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. Russia Women’s Health Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. Nordic Countries Women’s Health Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 39. Asia-Pacific Women’s Health Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 40. Asia-Pacific Women’s Health Drugs Market Share by Region (2019-2030)

Figure 41. China Women’s Health Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. Japan Women’s Health Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. South Korea Women’s Health Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. Southeast Asia Women’s Health Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. India Women’s Health Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. Australia Women’s Health Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 47. Latin America Women’s Health Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 48. Latin America Women’s Health Drugs Market Share by Country (2019-2030)

Figure 49. Mexico Women’s Health Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 50. Brazil Women’s Health Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 51. Middle East & Africa Women’s Health Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 52. Middle East & Africa Women’s Health Drugs Market Share by Country (2019-2030)

Figure 53. Turkey Women’s Health Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 54. Saudi Arabia Women’s Health Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 55. Bayer AG Revenue Growth Rate in Women’s Health Drugs Business (2019-2024)

Figure 56. Allergan Revenue Growth Rate in Women’s Health Drugs Business (2019-2024)

Figure 57. Merck & Co Revenue Growth Rate in Women’s Health Drugs Business (2019-2024)

Figure 58. Pfizer Inc Revenue Growth Rate in Women’s Health Drugs Business (2019-2024)

Figure 59. Amgen Revenue Growth Rate in Women’s Health Drugs Business (2019-2024)

Figure 60. Agile Therapeutics Inc Revenue Growth Rate in Women’s Health Drugs Business (2019-2024)

Figure 61. Ferring Pharmaceuticals Revenue Growth Rate in Women’s Health Drugs Business (2019-2024)

Figure 62. Mylan N.V. Revenue Growth Rate in Women’s Health Drugs Business (2019-2024)

Figure 63. Lupin (India) Revenue Growth Rate in Women’s Health Drugs Business (2019-2024)

Figure 64. Eli Lilly And Company Revenue Growth Rate in Women’s Health Drugs Business (2019-2024)

Figure 65. Novartis AG Revenue Growth Rate in Women’s Health Drugs Business (2019-2024)

Figure 66. Johnson & Johnson Revenue Growth Rate in Women’s Health Drugs Business (2019-2024)

Figure 67. Bottom-up and Top-down Approaches for This Report

Figure 68. Data Triangulation

Figure 69. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

120 Pages

Type: Report

Code: QYRE-Auto-34A13945

Thu May 02 00:00:00 UTC 2024

Add to Cart

Pre-filled Flush Syringes(≤5ml) - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages

Type: Report

Code: QYRE-Auto-31G14124

Thu May 02 00:00:00 UTC 2024

Add to Cart

OTC Topical Antifungals - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages

Type: Report

Code: QYRE-Auto-32D13978

Tue Apr 30 00:00:00 UTC 2024

Add to Cart

Fluoxetine Capsules - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages

Type: Report

Code: QYRE-Auto-2J14387

Tue Apr 30 00:00:00 UTC 2024

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions

Global Women’s Health Drugs Market Research Report 2024

Published Date: April 2024

Report Code: QYRE-Auto-9H3762

Global Women’s Health Drugs Market Research Report 2024

FEATURED COMPANIES

Women’s Health Drugs Market Size

Women’s Health Drugs Market

Report Scope

Scope of Women’s Health Drugs Market Report

Chapter Outline

FAQ for this report

Who are the main players in the Women’s Health Drugs Market report?

What are the Application segmentation covered in the Women’s Health Drugs Market report?

What are the Type segmentation covered in the Women’s Health Drugs Market report?

FEATURED COMPANIES

RELATED REPORTS